QA: SPRUCE BIOSCIENCES INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001683553_2023_SPRUCE_BIOSCIENCES_INC.pdf

Logs

Graph

Absolute values for 0001683553, SPRUCE BIOSCIENCES INC.

  xvar xval
0 AssetsCurrent 83,608,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 2,040,000
4 LiabilitiesCurrent 12,447,000
5 LiabilitiesNoncurrent 4,715,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,085,000
9 ResearchAndDevelopmentExpense 35,198,000
10 remainder_Expenses 420,000
11 remainder_Revenues 1,523,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -374,000
  yvar yval
0 Assets 85,648,000
1 Liabilities 17,162,000
2 Expenses 47,703,000
3 Revenues 1,523,000
4 StockholdersEquity 68,486,000
5 NetIncome -46,180,000
6 ComprehensiveNetIncome -46,367,000
7 BaseVar 76,205,000
8 EconomicCapitalRatio 1.39

Edgar->Model Mapping

Feature Distribution

Change over Time